The downregulation of Annexin A2 has been reported in several cancers (esophageal squamous cell carcinoma, oral squamous cell carcinoma, and prostate cancer) [61,62], and might have an effect on PCNA migration to the membrane. Here, ANXA2 is linked to cancer.